Folliman
Established Member
- Reaction score
- 204
Just trying to bring some hope to everyone,
As you may know Fevipiprant is going through multiple phase 3 trials at the moment.
https://www.evaluate.com/vantage/ar...ing-events-novartiss-asthma-zeal-and-alnylams
It will take 6 to 10 months to process the file to make it commercially available.
If they wait till all their trials end, Novartis will be filing around April 2020, which means that if approved the drug could be available to everyone some time between October 2020 and February 2021.
I was disappointed when Fevi's phase 3 clinical trials were rescheduled to conclude on December 2019 instead of the initially planned November 2018, it really sucked, but now the trials (the step that requires the most time and money) are almost out of the way.
This is a very exciting time.
Edit:
Update December 5th,
Novartis is still planning to file the new drug application in 2020. Fingers crossed.
https://www.novartis.com/sites/www....05-novartis-r-d-day-investor-presentation.pdf
Edit:
GAME OVER
The last trials failed:
https://www.fiercebiotech.com/biotech/novartis-dumps-asthma-program-after-another-set-phase-3-flops
As you may know Fevipiprant is going through multiple phase 3 trials at the moment.
https://www.evaluate.com/vantage/ar...ing-events-novartiss-asthma-zeal-and-alnylams
It will take 6 to 10 months to process the file to make it commercially available.
If they wait till all their trials end, Novartis will be filing around April 2020, which means that if approved the drug could be available to everyone some time between October 2020 and February 2021.
I was disappointed when Fevi's phase 3 clinical trials were rescheduled to conclude on December 2019 instead of the initially planned November 2018, it really sucked, but now the trials (the step that requires the most time and money) are almost out of the way.
This is a very exciting time.
Edit:
Update December 5th,
Novartis is still planning to file the new drug application in 2020. Fingers crossed.
https://www.novartis.com/sites/www....05-novartis-r-d-day-investor-presentation.pdf
Edit:
GAME OVER
The last trials failed:
https://www.fiercebiotech.com/biotech/novartis-dumps-asthma-program-after-another-set-phase-3-flops
Last edited: